Immune Indicator Changes in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs: A Prognostic Biomarker Analysis.

J Hepatocell Carcinoma · 2024 · PMC11512558 · PMID 39465041

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

33 , 34 In this study, both the OR group ( p =0.027) and OR-nPD subgroup ( p =0.029) showed a decreasing trend in CFB expression.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.